Xiaoguang Luo - Publications
Affiliations: | University of Nebraska Medical Center, Omaha, NE, United States |
Year | Citation | Score | |||
---|---|---|---|---|---|
2016 | Wang XH, Xie X, Luo XG, Shang H, He ZY. Inhibiting purinergic P2X7 receptors with the antagonist brilliant blue G is neuroprotective in an intranigral lipopolysaccharide animal model of Parkinson's disease. Molecular Medicine Reports. PMID 28035410 DOI: 10.3892/mmr.2016.6070 | 0.302 | |||
2012 | Luo XG, Chen SD. The changing phenotype of microglia from homeostasis to disease. Translational Neurodegeneration. 1: 9. PMID 23210447 DOI: 10.1186/2047-9158-1-9 | 0.306 | |||
2006 | Luo XG, Wang H, Zhou J, Yan R, Wu Z, Zhang CD, Wang QS. Beneficial effects of BV2 cell on proliferation and neuron-differentiating of mesenchymal stem cells in the circumstance of injured PC12 cell supernatant. Neuroscience Bulletin. 22: 221-6. PMID 17704836 | 0.335 | |||
2003 | Ikezu T, Luo X, Weber GA, Zhao J, McCabe L, Buescher JL, Ghorpade A, Zheng J, Xiong H. Amyloid precursor protein-processing products affect mononuclear phagocyte activation: pathways for sAPP- and Abeta-mediated neurotoxicity. Journal of Neurochemistry. 85: 925-34. PMID 12716424 DOI: 10.1046/J.1471-4159.2003.01739.X | 0.472 | |||
2003 | Luo X, Weber GA, Zheng J, Gendelman HE, Ikezu T. C1q-calreticulin induced oxidative neurotoxicity: relevance for the neuropathogenesis of Alzheimer's disease. Journal of Neuroimmunology. 135: 62-71. PMID 12576225 DOI: 10.1016/S0165-5728(02)00444-7 | 0.463 | |||
Show low-probability matches. |